| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |